Theravance Biopharma
TBPH
TBPH
125 hedge funds and large institutions have $1.11B invested in Theravance Biopharma in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 42 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
15% less capital invested
Capital invested by funds: $1.32B → $1.11B (-$203M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
96% less call options, than puts
Call options by funds: $39K | Put options by funds: $1.03M
Holders
125
Holding in Top 10
1
Calls
$39K
Puts
$1.03M
Top Buyers
| 1 | +$49.2M | |
| 2 | +$25.6M | |
| 3 | +$9.49M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.62M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.57M |
Top Sellers
| 1 | -$92.4M | |
| 2 | -$23.1M | |
| 3 | -$7.03M | |
| 4 |
Morgan Stanley
New York
|
-$3.05M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.01M |